Skip to content Skip to footer
Subscribe Now
MAGAZINE

PharmaShots Magazine-May-2025 Edition

Automation remained a quintessential force throughout 2024 in shaping the biopharma industry. 2025 on the other hand is experiencing advanced applications of automated tools and enablers in different aspects of drugs life cycles. PharmaShots through this magazine navigates automated packaging by decrypting the complexities of automation.  The magazine unfolds the role of automation in biopharma…
May 8, 2025

Read more

PharmaShots Magazine-April-2025 Edition
MAGAZINE

PharmaShots Magazine-April-2025 Edition

Emerging technologies holds a promising foothold in redefining the aspects of preventative, diagnostic, therapeutic, and patient care in the healthcare landscape. 3D Bioprinting offers innovative approach to addressing unmet healthcare needs with efficacious precision medicine in life-threatening conditions and developing therapies and medical devices that mimic complex human physiology.  In April, PharmaShots Magazine is exploring…
April 10, 2025

Read more

Spotlight Interview_Nazeen Rahman
SPOTLIGHT

Reuters Pharma 2025: Pre-Conference Talks Featuring Nazneen Rahman

In this thought-provoking Podcast, Nazneen Rahman Founder and CEO of YewMaker shares a glimpse of her upcoming presentation at the Reuters Pharma 2025 event on “Accelerate Access to Medicine: Unite for Global Health Equity” Nazneen talks about fostering science-based scalable solutions to promote sustainability in the biopharma industry. PharmaShots was delighted to learn about YewMaker’s…
April 8, 2025

Read more

Spotlight Interview_Konrad Dobschuetz
SPOTLIGHT

Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad Dobschuetz

Konrad Dobschuetz, Founder Director at Leap Advisory & Intelligence will be conducting a workshop at the upcoming Reuters Events Pharma 2025 on the topic “Patient Centricity”. In the exclusive discussion with PharmaShots, Konrad addresses the need for biopharma companies to achieve a patient mindset to deliver patient-centric care and enhance the patient experience. Konrad believes…
April 4, 2025

Read more

PharmaShots Magazine-March-2025 Edition
MAGAZINE

PharmaShots Magazine-March-2025 Edition

Did you know that 60 percent of pharmaceutical production is outsourced? As drug development costs rise, CDMOs have become safe havens for biopharma companies by offering scalable, cost-effective, and cutting-edge technology solutions for drug development and manufacturing.   In March, PharmaShots Magazine is navigating the evolving Biopharma CDMO frontier by decoding trends, illustrative infographics, thought-provoking articles,…
March 13, 2025

Read more

Reuters Events Pharma USA 2025
EVENTS

Reuters Events: Pharma USA 2025

Where disruption meets direction  In the past year, pharma has witnessed disruption in the external environment and internal restructure. We’ve reorganized for patients and customers – but it’s one thing to change a job title, another to transform outcomes. But how do you plan for the next wave of change across technology, regulations and expectations? For over…
February 14, 2025

Read more

Prescription Drugs Top 20 2024
TOP 20

Top 20 Prescription Drugs of 2024

Shots: Driven by an endless pursuit of innovation, the biopharma industry is working tirelessly to bring new-age therapies to patients with serious health conditions and lifestyle-influenced diseases In 2023, the global prescription drug market size was valued at $1162.61B and is anticipated to reach $2151.63B by 2032 registering a CAGR of 7.1 %. Keytruda ranks 1st…
October 31, 2024

Read more

Spotlight Interview_Nick Kadysh
SPOTLIGHT

CXO Talks: Nick Kadysh the Founding CEO & President at PharmAla Biotech, in an Illuminating Dialogue Exchange with PharmaShots

In the second reprise of our Complimentary Exclusive Video Interview, we had the pleasure to speak with Nick Kadysh, the Founding CEO and President of PharmAla Biotech. Our complimentary exclusive video interview is an initiative to voice the global biopharma leaders by offering them a platform to shed light on the developments in the healthcare…
August 12, 2024

Read more

Know Your Investor: Invus (July’24 Edition)
INSIGHTS+

Know Your Investor: Invus (July’24 Edition)

Shots:    Backed with an evergreen investment strategy, Invus makes investments across several company stages ranging from early growth to turnarounds   In 2023, Invus participated in 6 investment rounds in around 29 companies focusing on biopharma, manufacturing & services, and devices   For a curated report on a specific investor or venture capital, reach out to us…
July 17, 2024

Read more

Load more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]